This pricing structure removes barriers to reaching your optimal dose and ensures that advancing your therapy never triggers unexpected cost increases tied to your injection strength
Clinically responsible medical providers will not prescribe retatrutide until it has completed clinical trials, received FDA approval, and established legal prescribing and pharmacy dispensing pathways
Erythrocyte metabolic pathway-related protein [adenosine A2B receptor (ADORA2B), erythrocyte equilibrative nucleoside transporter 1 (eENT1), sphingosine kinase 1 (SPHK1), phospho-SPHK1, bisphosphoglycerate mutase (BPGM), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH)] levels were assessed by Western blotting
Sattar N, Lee MMY, Kristensen SL, Branch KRH, Del Prato S, Khurmi NS, et al